DrugBiological
Infliximab clinical trials
Also written Remicade, SCH 215596, Remsima and TA-650.
Includes 2 studies of GP1111 and 2 studies of BCD-055.
- studies test it
- 244
- open now
- 30
- in phase 3
- 82
- first study started
- 1995
Keep track of what changes. Save the Infliximab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
236 studies that test it; most in 2003 (18)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 2 |
| 1997 | 1 |
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 8 |
| 2003 | 18 |
| 2004 | 5 |
| 2005 | 14 |
| 2006 | 14 |
| 2007 | 18 |
| 2008 | 11 |
| 2009 | 8 |
| 2010 | 10 |
| 2011 | 5 |
| 2012 | 14 |
| 2013 | 12 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 10 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 23
- Phase 2
- 61
- Phase 3
- 82
- Phase 4
- 73
- No phase
- 21
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 84 · Other 160
Merck Sharp & Dohme LLC (24) · Centocor, Inc. (20) · Tanabe Pharma Corporation (7) · Emory University (5) · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (5) · Celltrion (5) · Massachusetts General Hospital (4) · National Institute of Allergy and Infectious Diseases (NIAID) (4)
Often tested with
Tested in the same studies.
Adalimumab (18) · Etanercept (13) · Methotrexate (12) · Azathioprine (9) · Golimumab (8) · Certolizumab Pegol (7) · Abatacept (5) · Tocilizumab (5)
Studies
Open first, then newest update. How each study uses Infliximab is read from its arms, and is right about nine times in ten.
Testing it · 244
- Infliximab for Immune Checkpoint Inhibitor Associated AKIRecruitingPhase 4Massachusetts General HospitalNCT07683975Written as Infliximab
- Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory MyelomaRecruitingPhase 2Naresh BummaNCT07657312Written as Infliximab
- Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease PatientsRecruitingPhase 4Taizhou Mabtech Pharmaceutical Co.,LtdNCT05906576Written as Infliximab
- Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingPhase 2University of PennsylvaniaNCT06941376Written as Infliximab
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingPhase 1M.D. Anderson Cancer CenterNCT03819296Written as Infliximab
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingPhase 2NYU Langone HealthNCT07138898Written as Infliximab
- Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)RecruitingPhase 2University of LiverpoolNCT03684278Written as Infusion of 5 mg/kg Infliximab
- Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye DiseaseNot yet recruitingPhase 2Instituto de Oftalmología Fundación Conde de ValencianaNCT07671222Written as Infliximab 0.1%
- Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's DiseaseNot yet recruitingNot applicableNantes University HospitalNCT05584228Written as Azathioprine + infliximab
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingPhase 3University of NebraskaNCT03414502Written as Infliximab
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingPhase 1/2University of California, San FranciscoNCT02638701Written as Infliximab
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingPhase 4University of California, San FranciscoNCT07352566Written as Infliximab
- Anti-Inflammatory Challenge in SchizophreniaRecruitingPhase 4Emory UniversityNCT05823532Written as Infliximab
- Topical Infliximab in Eyes With Penetrating KeratoplastyRecruitingPhase 1/2Centre hospitalier de l'Université de Montréal (CHUM)NCT05180994Written as Topical infliximab
- Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained RemissionRecruitingNot applicableMarmara UniversityNCT07491913Written as Infliximab
- Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's DiseaseNot yet recruitingPhase 4Chinese Medical AssociationNCT07417696Written as Palmitoleic Acid + Infliximab
- Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO TrialNot yet recruitingPhase 2Asian Institute of Gastroenterology, IndiaNCT07297069Written as Infliximab
- Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative ColitisRecruitingPhase 2Medical University of LodzNCT06453317Written as Infliximab
- Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via InfliximabRecruitingPhase 2Massachusetts General HospitalNCT06136546Written as Infliximab
- PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel DiseaseRecruitingNot applicablePontificia Universidad Catolica de ChileNCT06758024Written as Infliximab
See all 244 studies that test Infliximab →
Given in every arm · 9 — Infliximab is usual care beside what is tested
- Precise Infliximab Exposure and Pharmacodynamic ControlRecruitingPhase 2/3Children's Hospital Medical Center, CincinnatiNCT05660746Written as Infliximab
- InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's DiseaseRecruitingPhase 3Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT06059989Written as Infliximab subcutaneous
- HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's DiseaseNot yet recruitingPhase 4Sixth Affiliated Hospital, Sun Yat-sen UniversityNCT05813860Written as Infliximab
- Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative ColitisCompletedPhase 4Sixth Affiliated Hospital, Sun Yat-sen UniversityNCT05205603Written as Infliximab
- Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney TransplantationCompletedNot applicableInstitute for Clinical and Experimental MedicineNCT02711202Written as Remicade
- Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled StudyActive, not recruitingNot applicableShanghai 10th People's HospitalNCT07149441Written as infliximab
- N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's DiseaseStatus unknownNot applicableSixth Affiliated Hospital, Sun Yat-sen UniversityNCT04761952Written as infliximab
- Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory DiseasesTerminatedNot applicableUniversity Hospital, LilleNCT03370601Written as Infliximab
- Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00984568Written as Infliximab
As the comparator · 21 — what is tested is compared with Infliximab
- PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureNot yet recruitingPhase 2Therakos LLCNCT07619898Written as Infliximab
- Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）RecruitingPhase 4Xijing Hospital of Digestive DiseasesNCT07550673Written as Infliximab
- Combined Immunosuppression for Pediatric Crohn's DiseaseRecruitingPhase 4Children's Hospital of Fudan UniversityNCT05043870Written as Infliximab
- Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's DiseaseNot yet recruitingPhase 4Chinese Medical AssociationNCT07415473Written as Infliximab
- AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative ColitisNot yet recruitingNot applicableFederico II UniversityNCT05931458Written as Infliximab
- Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or MelanomaActive, not recruitingPhase 1/2M.D. Anderson Cancer CenterNCT04407247Written as Infliximab
- EPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisWithdrawnPhase 2Therakos LLCNCT06646016Written as Infliximab
- A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)CompletedPhase 3Incyte CorporationNCT03112603Written as Infliximab
- Biologic Tapering Study of TNF Inhibitors in Axial SpondyloarthritisActive, not recruitingPhase 4University Health Network, TorontoNCT05115903Written as Standard dose of TNFi
- Immune Modulators for Treating COVID-19CompletedPhase 3Daniel BenjaminNCT04593940Written as Infliximab
- Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationTerminatedPhase 4Mario Negri Institute for Pharmacological ResearchNCT03100253Written as Infliximab
- Exclusive Enteral Nutrition vs. Infliximab in Chinese CD PatientsWithdrawnPhase 4Children's Hospital of Fudan UniversityNCT04530877Written as Infliximab
- A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsCompletedPhase 3Hoffmann-La RocheNCT02136069Written as Infliximab
- To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedPhase 3CelltrionNCT03707535Written as Remicade
- A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or AdalimumabTerminatedPhase 2Genentech, Inc.NCT00808210Written as Infliximab
- Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic FactorsTerminatedPhase 3IRCCS Burlo GarofoloNCT03221166Written as Infliximab
- Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for InjectionStatus unknownPhase 3Genor Biopharma Co., Ltd.NCT04178850Written as Infliximab
- A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyCompletedPhase 3Samsung Bioepis Co., Ltd.NCT01936181Written as Remicade (infliximab)
- Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative ColitisStatus unknownPhase 4Istituto Clinico HumanitasNCT03151525Written as Infliximab
- A Phase II Efficacy Study in Fistulizing Crohn's Disease PatientsCompletedPhase 2Novartis PharmaceuticalsNCT01355614Written as Infliximab
Showing 20 of 21.
Codes
What other systems call Infliximab · ClinicalTrials.gg INT006568
- MeSH (NLM) D000069285InfliximabConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) B72HH48FLUINFLIXIMABConfirmed FDA, NLM, Wikidata
- RxNorm 191831Confirmed FDA, Wikidata
- Wikidata Q415264infliximabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1789InfliximabOne source FDA
- DrugBank DB00065One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069285 | Infliximab | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | B72HH48FLU | INFLIXIMAB | Confirmed FDA, NLM, Wikidata |
| RxNorm | 191831 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415264 | infliximab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1789 | Infliximab | One source FDA |
| DrugBank | DB00065 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.